Zimmer Biomet Holdings, Inc. (ZBH) trades at a trailing P/E of 25.6, forward P/E of 11.5. Trailing earnings yield is 3.90%, forward earnings yield 8.70%. PEG 0.08 (Peter Lynch undervalued ≤1.0). Graham Number is $72.00.
Criteria proven by this page:
Overall SharesGrow Score: 63/100 with 2/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | 65.5 | 0.14 | 2.07 | 2.61 | 0.94% |
| 2017 | 13.0 | 0.03 | 2.01 | 3.03 | 0.82% |
| 2018 | -54.0 | 0.45 | 1.82 | 2.58 | 0.95% |
| 2019 | 26.3 | -0.07 | 2.40 | 3.73 | 0.66% |
| 2020 | -222.8 | 1.99 | 2.54 | 5.05 | 0.64% |
| 2021 | 64.0 | -0.16 | 2.03 | 3.77 | 0.78% |
| 2022 | 115.5 | -2.69 | 2.22 | 3.85 | 0.75% |
| 2023 | 24.8 | 0.07 | 2.04 | 3.43 | 0.79% |
| 2024 | 23.7 | -2.53 | 1.72 | 2.79 | 0.91% |
| 2025 | 25.2 | -1.26 | 1.40 | 2.16 | 1.07% |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $1.50 | $7.68B | $302.9M | 3.9% |
| 2017 | $9.03 | $7.82B | $1.84B | 23.5% |
| 2018 | $-1.86 | $7.93B | $-379.2M | -4.8% |
| 2019 | $5.47 | $7.98B | $1.13B | 14.2% |
| 2020 | $-0.66 | $7.02B | $-137.4M | -2% |
| 2021 | $1.91 | $6.83B | $401.6M | 5.9% |
| 2022 | $1.38 | $6.94B | $231.4M | 3.3% |
| 2023 | $4.88 | $7.39B | $1.02B | 13.8% |
| 2024 | $4.43 | $7.68B | $903.8M | 11.8% |
| 2025 | $3.55 | $8.23B | $705.2M | 8.6% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $8.40 | $8.19 – $8.47 | $8.56B | $8.44B – $8.62B | 16 |
| 2027 | $9.01 | $8.61 – $9.38 | $8.88B | $8.72B – $9.05B | 16 |
| 2028 | $9.59 | $7.35 – $11.50 | $9.21B | $9.19B – $9.23B | 4 |
| 2029 | $10.34 | $10.14 – $10.54 | $9.69B | $9.54B – $9.84B | 2 |
| 2030 | $10.91 | $10.69 – $11.12 | $10.2B | $10.04B – $10.35B | 2 |
